This is a Validated Antibody Database (VAD) review about cow TP53, based on 54 published articles (read how Labome selects the articles), using TP53 antibody in all methods. It is aimed to help Labome visitors find the most suited TP53 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TP53 synonym: cellular tumor antigen p53; p53 tumor suppressor phosphoprotein; tumor protein 53; tumor protein p53 (Li-Fraumeni syndrome); tumor suppressor p53

others
  • western blot; human; loading ...; fig 1c
 TP53 antibody (Thermo Fisher, DO-1) was used in western blot on human samples (fig 1c). Oncotarget (2018) ncbi
Invitrogen
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 4a
Invitrogen TP53 antibody (Labvision, MS-187P) was used in western blot on human samples (fig 4a). Cell Rep (2018) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 1c
Invitrogen TP53 antibody (Thermo Fisher, DO-1) was used in western blot on human samples (fig 1c). Oncotarget (2018) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 1a
Invitrogen TP53 antibody (Invitrogen, DO1) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 1a). Science (2018) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; tbl 2
In order to review the relevance of BRAF V600E mutation to colorectal cancer, Invitrogen TP53 antibody (Thermo Fisher Scientific, D07) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 2). J Korean Med Sci (2017) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
In order to analyze high-risk HPV incidence, prognostic biomarkers, and outcome in HIV-positive and -negative patients with head and neck squamous cell cancer, Invitrogen TP53 antibody (Thermo Scientific, DO-1) was used in immunohistochemistry - paraffin section on human samples (fig 2). Mol Cancer Res (2017) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to find prognostic clusters for breast cancer, Invitrogen TP53 antibody (NeoMarkers, DO7) was used in immunohistochemistry - paraffin section on human samples (fig 1). BMC Cancer (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; loading ...; fig 3c
In order to describe the mechanism behind the association between single nucleotide polymorphism rs55705857 and glioma development., Invitrogen TP53 antibody (Thermo Fisher, A00021-IFU) was used in immunohistochemistry on human samples (fig 3c). Sci Rep (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:600; fig 1
In order to study 3 cases of uterine adenomyosis/adenomyotic cysts of the cervical stump leading to serous carcinoma, Invitrogen TP53 antibody (Thermo, DO-7) was used in immunohistochemistry on human samples at 1:600 (fig 1). Diagn Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 1b
In order to evaluate the diagnostic value of stathmin expression in samples of vulvar intraepithelial neoplastic lesions, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1b). J Clin Pathol (2016) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:1000; tbl 2
In order to perform morphological, p53 immunohistochemical, and TP53 gene mutational analyses of pelvic carcinosarcomas, Invitrogen TP53 antibody (Thermo Fisher, DO-7) was used in immunohistochemistry on human samples at 1:1000 (tbl 2). Virchows Arch (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; fig 4
In order to study APC/C(Cdh1) function, Invitrogen TP53 antibody (Thermo Scientific, MS-186) was used in western blot on human samples at 1:1000 (fig 4). Nucleic Acids Res (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig 2a
In order to ask if p53 status of patients with hepatocellular carcinoma affects the efficacy of herpes simplex virus-1 thymidine kinase/ganciclovir therapy, Invitrogen TP53 antibody (NeoMarkers, DO-1) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (DO-7)
  • western blot; human; loading ...; fig 1b
In order to develop a method to examine protein oligomerization in cells using a single electrophoresis gel, Invitrogen TP53 antibody (Thermo Fisher, DO-7) was used in western blot on human samples (fig 1b). Anal Bioanal Chem (2016) ncbi
mouse monoclonal (DO-1)
  • western blot; human; loading ...; fig s2a
In order to identify and study roles for MAP3K8 in high-grade serous ovarian carcinomas, Invitrogen TP53 antibody (Thermoscientific, MS-187-PO) was used in western blot on human samples (fig s2a). Nat Commun (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry; human; 1:200; fig 3
In order to assess a protocol for acquiring portal venous blood through endoscopic ultrasound, Invitrogen TP53 antibody (Thermo Scientific, p53 Ab-6 (Clone DO-1)) was used in immunohistochemistry on human samples at 1:200 (fig 3). Gastroenterology (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; fig 8
In order to assess links between telomere-dysfunction and centrosome defects in early breast carcinogenesis, Invitrogen TP53 antibody (Thermo Scientific, MS-186) was used in western blot on human samples at 1:1000 (fig 8). Oncotarget (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen TP53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Pathol Res Pract (2015) ncbi
mouse monoclonal (DO-1)
  • immunoprecipitation; human
  • western blot; human
In order to study the homo- and heterodimerization of an E3 ligase MDM2, Invitrogen TP53 antibody (Labvision, DO-1) was used in immunoprecipitation on human samples and in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:400
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on human samples at 1:400. Gynecol Oncol (2015) ncbi
mouse monoclonal (DO-7)
  • western blot; human; fig 1
In order to report that p53 and DeltaNp63alpha are transcriptional partners for SMAD proteins, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in western blot on human samples (fig 1). Mol Cancer Res (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:400
In order to describe a patient diagnosed with a noninvasive intestinal-type mucinous ovarian borderline tumor presenting with pleural metastases, Invitrogen TP53 antibody (Thermo Fisher Scientific, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:400. Int J Gynecol Pathol (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Invitrogen TP53 antibody (LabVisio, DO-7) was used in immunohistochemistry - paraffin section on human samples . APMIS (2015) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen TP53 antibody (Thermo Scientific, MS187) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Invitrogen TP53 antibody (LabVision, DO-7) was used in immunohistochemistry on human samples at 1:50. Arch Dermatol Res (2015) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:250
Invitrogen TP53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:250. Am J Clin Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; rat; 1:100; fig 1, 2, 3
In order to study the effect of artificial food colors and additives on laryngeal histomorphology and immunohistochemical expression in maternally exposed rats, Invitrogen TP53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on rat samples at 1:100 (fig 1, 2, 3). J Environ Pathol Toxicol Oncol (2014) ncbi
mouse monoclonal (DO-1)
  • western blot; human; 1:1000
In order to describe a new polymeric-phospholipidic hybrid delivery system which enhanced the accumulation and activity of Dox in all tested cancer cell lines, Invitrogen TP53 antibody (NeoMarkers, Do-1) was used in western blot on human samples at 1:1000. J Biomed Nanotechnol (2014) ncbi
mouse monoclonal (DO-1)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunohistochemistry; human; 1:100
In order to study the predictive and prognostic value of a range of biomarkers in pre-treatment biopsies from patients with advanced cancer of the larynx, Invitrogen TP53 antibody (Lab Vision, DO-1) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunohistochemistry on human samples at 1:100. Laryngoscope (2014) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human
In order to report and characterize two cases of accessory breast cancer occurring concurrently with primary invasive breast cancer, Invitrogen TP53 antibody (Zymed, DO-7) was used in immunohistochemistry on human samples . Cancer Biol Med (2012) ncbi
mouse monoclonal (DO-7)
  • immunocytochemistry; human; 1:200; fig 1
  • western blot; human; 1:1000; fig 2
In order to analyze the activity of p53 after stimulation with p53-dependent and -independent DNA damaging agents during human herpesvirus-infection, Invitrogen TP53 antibody (Life Technologies, DO-7) was used in immunocytochemistry on human samples at 1:200 (fig 1) and in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; tbl 3
In order to study the expression of Ki-67, tumor protein P53, P21, and P27 in 8 paired WHO grade II astrocytoma samples, Invitrogen TP53 antibody (Zymed, Do-7) was used in immunohistochemistry - paraffin section on human samples (tbl 3). Chin J Cancer (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:30
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen TP53 antibody (Lab Vision, MS-186) was used in immunohistochemistry - paraffin section on human samples at 1:30. Int J Oncol (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; fig 1
In order to determine the roles of p53 and hMSH2 proteins in oral squamous cell carcinoma and oral dysplastic lesions, Invitrogen TP53 antibody (Zymed, Do7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oral Oncol (2012) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 8
In order to assess antibodies to use for the diagnosis of metastatic adenocarcinomas, Invitrogen TP53 antibody (ZYMED, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8). Diagn Cytopathol (2011) ncbi
mouse monoclonal (DO-1)
  • western blot; human; fig 7
  • western blot; mouse; fig 7
In order to examine the role of mitochondrial p32 in ARF-induced apoptosis, Invitrogen TP53 antibody (Lab Vision, DO1) was used in western blot on human samples (fig 7) and in western blot on mouse samples (fig 7). Cancer Cell (2008) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human
In order to examine apoptosis and cell proliferation in synovial sarcoma, Invitrogen TP53 antibody (Zymed, D07) was used in immunohistochemistry - paraffin section on human samples . Eur J Cancer Prev (2006) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry; human; 1:50
In order to discuss recurrent intracranial hemangiopericytoma with multiple metastases, Invitrogen TP53 antibody (Zymed Laboratories, do-7) was used in immunohistochemistry on human samples at 1:50. Chin Med J (Engl) (2006) ncbi
mouse monoclonal (DO-7)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
In order to test if Ki-67, proliferating cell nuclear antigen, silver-staining nucleolar organizer regions and p53 could differentiate spontaneous abortions from subtypes of gestational trophoblastic diseases, Invitrogen TP53 antibody (Zymed Laboratories, clone DO7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Am J Obstet Gynecol (2001) ncbi
Abcam
mouse monoclonal (PAb 240)
  • immunoprecipitation; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 1a, 1b
Abcam TP53 antibody (Abcam, ab26) was used in immunoprecipitation on human samples (fig 4a) and in western blot on human samples (fig 1a, 1b). Redox Biol (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; 1:1000; loading ...; fig s3b
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples at 1:1000 (fig s3b). J Clin Invest (2019) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; loading ...; fig 4b
Abcam TP53 antibody (Abcam, ab26) was used in western blot on rat samples (fig 4b). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig 5a
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples (fig 5a). J Mol Neurosci (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; loading ...; fig 6a
  • western blot; human; loading ...; fig 6a
Abcam TP53 antibody (Abcam, ab26) was used in western blot on rat samples (fig 6a) and in western blot on human samples (fig 6a). Cancer Lett (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; rat; 1:1000; loading ...; fig 6c
Abcam TP53 antibody (Abcam, ab26) was used in western blot on rat samples at 1:1000 (fig 6c). Biosci Rep (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; mouse; 1:500; loading ...; fig 2d
Abcam TP53 antibody (Abcam, Ab26) was used in western blot on mouse samples at 1:500 (fig 2d). Kidney Blood Press Res (2018) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig s6
Abcam TP53 antibody (Abcam, Ab240) was used in western blot on human samples (fig s6). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (PAb 240)
  • immunocytochemistry; human; loading ...; fig s9
Abcam TP53 antibody (Abcam, 240) was used in immunocytochemistry on human samples (fig s9). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (PAb 240)
  • western blot; human; loading ...; fig 2a
Abcam TP53 antibody (Abcam, ab26) was used in western blot on human samples (fig 2a). Oncotarget (2015) ncbi
Bio-Rad
mouse monoclonal (DO-7)
  • western blot; human; 1:1000; loading ...; fig 4a
Bio-Rad TP53 antibody (AbD Serotec, MCA1703) was used in western blot on human samples at 1:1000 (fig 4a). Mol Oncol (2015) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology TP53 antibody (Cell Signaling, 2528) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 5
Cell Signaling Technology TP53 antibody (CST, 2528) was used in western blot on human samples (fig 5). Nucleic Acids Res (2016) ncbi
EMD Millipore
rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 1b
EMD Millipore TP53 antibody (EMD Millipore, 06-1283) was used in immunocytochemistry on human samples (fig 1b). PLoS ONE (2018) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s11c
EMD Millipore TP53 antibody (Merck Millipore, 06-1283) was used in western blot on human samples at 1:1000 (fig s11c). Nat Commun (2018) ncbi
rabbit polyclonal
  • western blot; human; fig 4a
EMD Millipore TP53 antibody (Millipore, 06-1283) was used in western blot on human samples (fig 4a). Hum Mol Genet (2015) ncbi
Articles Reviewed
  1. Rong X, Rao J, Li D, Jing Q, Lu Y, Ji Y. TRIM69 inhibits cataractogenesis by negatively regulating p53. Redox Biol. 2019;22:101157 pubmed publisher
  2. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  3. Fu J, Yu W, Jiang D. Acidic pH promotes nucleus pulposus cell senescence through activating the p38 MAPK pathway. Biosci Rep. 2018;38: pubmed publisher
  4. Luff S, Kao C, Papoutsakis E. Role of p53 and transcription-independent p53-induced apoptosis in shear-stimulated megakaryocytic maturation, particle generation, and platelet biogenesis. PLoS ONE. 2018;13:e0203991 pubmed publisher
  5. Leslie P, Franklin D, Liu Y, Zhang Y. p53 Regulates the Expression of LRP1 and Apoptosis through a Stress Intensity-Dependent MicroRNA Feedback Loop. Cell Rep. 2018;24:1484-1495 pubmed publisher
  6. Bernal A, Moltó Abad M, Dominguez D, Tusell L. Acute telomere deprotection prevents ongoing BFB cycles and rampant instability in p16INK4a-deficient epithelial cells. Oncotarget. 2018;9:27151-27170 pubmed publisher
  7. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  8. Wang J, Wang F, Zhu J, Song M, An J, Li W. Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. J Mol Neurosci. 2018;65:102-109 pubmed publisher
  9. Wang Z, Ding Y, Wang X, Lu S, Wang C, He C, et al. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT. Cancer Lett. 2018;428:21-33 pubmed publisher
  10. Jin L, Lu J, Gao J. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Biosci Rep. 2018;38: pubmed publisher
  11. Yang X, Ding Y, Yang M, Yu L, Hu Y, Deng Y. Nestin Improves Preeclampsia-Like Symptoms by Inhibiting Activity of Cyclin-Dependent Kinase 5. Kidney Blood Press Res. 2018;43:616-627 pubmed publisher
  12. Li F, Liu J, Bao R, Yan G, Feng X, Xu Y, et al. Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis. Nat Commun. 2018;9:508 pubmed publisher
  13. Shin C, Lee M, Han J, Jeong S, Ryu B, Chi S. Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions. Proc Natl Acad Sci U S A. 2017;114:5683-5688 pubmed publisher
  14. Jang M, Kim S, Hwang D, Kim W, Lim S, Kim W, et al. BRAF-Mutated Colorectal Cancer Exhibits Distinct Clinicopathological Features from Wild-Type BRAF-Expressing Cancer Independent of the Microsatellite Instability Status. J Korean Med Sci. 2017;32:38-46 pubmed publisher
  15. Walline H, Carey T, Goudsmit C, Bellile E, D Souza G, Peterson L, et al. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res. 2017;15:179-188 pubmed publisher
  16. Bauer M, Joerger A, Fersht A. 2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells. Proc Natl Acad Sci U S A. 2016;113:E5271-80 pubmed publisher
  17. Guerra E, Cimadamore A, Simeone P, Vacca G, Lattanzio R, Botti G, et al. p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading. BMC Cancer. 2016;16:649 pubmed publisher
  18. Oktay Y, Ãœlgen E, Can Ã, Akyerli C, Yüksel Å, Erdemgil Y, et al. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep. 2016;6:27569 pubmed publisher
  19. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed publisher
  20. Nooij L, Dreef E, Smit V, van Poelgeest M, Bosse T. Stathmin is a highly sensitive and specific biomarker for vulvar high-grade squamous intraepithelial lesions. J Clin Pathol. 2016;69:1070-1075 pubmed publisher
  21. Ardighieri L, Mori L, Conzadori S, Bugatti M, Falchetti M, Donzelli C, et al. Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship. Virchows Arch. 2016;469:61-9 pubmed publisher
  22. Ercilla A, Llopis A, Feu S, Aranda S, Ernfors P, Freire R, et al. New origin firing is inhibited by APC/CCdh1 activation in S-phase after severe replication stress. Nucleic Acids Res. 2016;44:4745-62 pubmed publisher
  23. Liu X, Wang S, Guo X, Wei F, Yin J, Zang Y, et al. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53. Oncotarget. 2016;7:18896-905 pubmed publisher
  24. Zheng F, Yue C, Li G, He B, Cheng W, Wang X, et al. Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nat Commun. 2016;7:10180 pubmed publisher
  25. Cubillos Rojas M, Schneider T, Sánchez Tena S, Bartrons R, Ventura F, Rosa J. Tris-acetate polyacrylamide gradient gel electrophoresis for the analysis of protein oligomerization. Anal Bioanal Chem. 2016;408:1715-9 pubmed publisher
  26. Gruosso T, Garnier C, Abélanet S, Kieffer Y, Lemesre V, Bellanger D, et al. MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas. Nat Commun. 2015;6:8583 pubmed publisher
  27. Kramer H, Lai C, Patel H, Periyasamy M, Lin M, Feller S, et al. LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner. Nucleic Acids Res. 2016;44:582-94 pubmed publisher
  28. Catenacci D, Chapman C, Xu P, Koons A, Konda V, Siddiqui U, et al. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound. Gastroenterology. 2015;149:1794-1803.e4 pubmed publisher
  29. Domínguez D, Feijoo P, Bernal A, Ercilla A, Agell N, Genescà A, et al. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress. Oncotarget. 2015;6:28238-56 pubmed publisher
  30. De Cesare M, Cominetti D, Doldi V, Lopergolo A, Deraco M, Gandellini P, et al. Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin. Oncotarget. 2015;6:13119-32 pubmed
  31. Kankaya D, Kiremitci S, Tulunay O, Baltaci S. Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome. Pathol Res Pract. 2015;211:505-12 pubmed publisher
  32. Leslie P, Ke H, Zhang Y. The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization. J Biol Chem. 2015;290:12941-50 pubmed publisher
  33. Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed publisher
  34. Balboni A, Cherukuri P, Ung M, DeCastro A, Cheng C, DiRenzo J. p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals. Mol Cancer Res. 2015;13:732-42 pubmed publisher
  35. Simons M, Nagtegaal I, Overbeek L, Flucke U, Massuger L, Bulten J. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases. Int J Gynecol Pathol. 2015;34:143-50 pubmed publisher
  36. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher
  37. Greve K, Lindgreen J, Terp M, Pedersen C, Schmidt S, Mollenhauer J, et al. Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability. Mol Oncol. 2015;9:437-49 pubmed publisher
  38. Choi H, Choi Y, Kang H, Lim E, Park S, Lee H, et al. PINK1 positively regulates HDAC3 to suppress dopaminergic neuronal cell death. Hum Mol Genet. 2015;24:1127-41 pubmed publisher
  39. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  40. Gurzu S, Ciortea D, Tamasi A, Golea M, Bodi A, Sahlean D, et al. The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin. Arch Dermatol Res. 2015;307:151-7 pubmed publisher
  41. Mingels M, Masadah R, Geels Y, Otte Holler I, de Kievit I, van der Laak J, et al. High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer. Am J Clin Pathol. 2014;142:213-21 pubmed publisher
  42. Basak K, Doguc D, Aylak F, Karadayi N, Gultekin F. Effects of maternally exposed food coloring additives on laryngeal histology in rats. J Environ Pathol Toxicol Oncol. 2014;33:123-30 pubmed
  43. Senkiv Y, Riabtseva A, Heffeter P, Boiko N, Kowol C, Jungwith U, et al. Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/ phospholipidic nanocarriers of doxorubicin. J Biomed Nanotechnol. 2014;10:1369-81 pubmed
  44. Bradford C, Kumar B, Bellile E, Lee J, Taylor J, D SILVA N, et al. Biomarkers in advanced larynx cancer. Laryngoscope. 2014;124:179-87 pubmed publisher
  45. Hao J, Yang C, Liu F, Yang Y, Li S, Li W, et al. Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review. Cancer Biol Med. 2012;9:197-201 pubmed publisher
  46. Kofod Olsen E, Møller J, Schleimann M, Bundgaard B, Bak R, Øster B, et al. Inhibition of p53-dependent, but not p53-independent, cell death by U19 protein from human herpesvirus 6B. PLoS ONE. 2013;8:e59223 pubmed publisher
  47. Yue W, Sai K, Wu Q, Xia Y, Yu S, Chen Z. Long-term molecular changes in WHO grade II astrocytomas following radiotherapy. Chin J Cancer. 2012;31:159-65 pubmed publisher
  48. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  49. Helal T, Fadel M, El Thobbani A, El Sarhi A. Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors. Oral Oncol. 2012;48:120-4 pubmed publisher
  50. Su X, Li G, Liu W, Xie B, Jiang Y. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol. 2011;39:900-8 pubmed publisher
  51. Itahana K, Zhang Y. Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell. 2008;13:542-53 pubmed publisher
  52. Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev. 2006;15:258-65 pubmed
  53. Cao Y, Zhang M, Wang J, Zhang W, Li G, Zhao J. Recurrent intracranial hemangiopericytoma with multiple metastases. Chin Med J (Engl). 2006;119:169-73 pubmed
  54. Kale A, Soylemez F, Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol. 2001;184:567-74 pubmed